Shanghai Docsim Biotech Co., Ltd.

Country/Region: China     State/Province: Shanghai

Main Products: Peptide

Company Introduction
Shanghai Docsim Biotech Co., Ltd. dedicated to the custom peptide synthesis, development, manufacture and marketing of diverse biochemicals.We provide customers with high quality, high efficiency of peptide synthesis services, with the most competitive prices .
Company Overview

Business Type: Exporter, Retailer

Year Established: 2006

Employees: 201 - 300 People

Plant Area: 10,000-30,000 square meters

Contact Information

Fax: 86-21-61218822

Business Information

Main Markets: South America 10% Africa 9% Eastern Asia 8% Domestic Market 8% North America 9% Eastern Europe 12% Southern Europe 9% Mid East 9% Northern Europe 10% Oceania 16%

Trade Capacity: FOB, CFR, DAF

Contract Manufacturing: Buyer Label Offered

Nearest Port: Shanghai

Trade & Financial Information

Annual Revenue: US$2.5 Million - US$5 Million

Total Revenue: US$2.5 Million - US$5 Million

Export Revenue: US$10 Million - US$50 Million

Annual Output: US$10 Million - US$50 Million

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 61% - 70%

Payment Modes: USD, EUR, GBP

Lead Time: 20 days

Import/Export Mode: Have Own Export License

Product Showcase
peptide

CL-Link > Health & Medicines in China Health & Medicines in Shanghai Health Care Supplement in China Health Care Supplement in Shanghai Dolutegravir in China Dolutegravir in Shanghai